Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae using a laboratory-developed high-throughput test for the...

Area of Science:

• Clinical microbiology
• Molecular diagnostics
• Respiratory infectious diseases

Background:

• Mycoplasma pneumoniae and Chlamydia pneumoniae are significant pathogens causing atypical pneumonia.
• Accurate and rapid diagnostic methods are crucial for managing outbreaks and patient care.

Purpose of the Study:

• To develop and validate a high-throughput multiplex real-time PCR assay for simultaneous detection of M. pneumoniae and C. pneumoniae.
• To assess the assay's performance characteristics, including sensitivity, specificity, and precision.

Main Methods:

• A laboratory-developed test (LDT) was created for the Hologic Panther Fusion system.
• The assay utilizes TaqMan® probes targeting the CARDS tx-gene (M. pneumoniae) and argR gene (C. pneumoniae).
• Validation involved external quality controls, defined bacterial concentrations, and frozen patient samples.

Main Results:

• The 95% limits of detection were 111 copies/mL for M. pneumoniae and 878 copies/mL for C. pneumoniae.
• The assay demonstrated 100% specificity against 30 related pathogens.
• Routine analysis of 56,773 samples showed a prevalence of 18.9% for M. pneumoniae and 1.5% for C. pneumoniae.

Conclusions:

• The developed multiplex real-time PCR assay is highly sensitive and specific for detecting M. pneumoniae and C. pneumoniae.
• The assay provides rapid sample processing, suitable for routine clinical use and outbreak surveillance.
• This diagnostic tool aids in the timely identification of atypical pneumonia agents.